Image de couverture de livre

Reorganizing the FDA is not a good idea: Former officials

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	The Brown University Child & Adolescent Psychopharmacology Update
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

FDA facing challenges: GAO
Publié: (2026)

FDA lifts bans on fruit vapes
Publié: (2026)

From the FDA: Nicotine pouches can be dangerous to children
Publié: (2025)

FDA urges higher naloxone doses in fentanyl era
par: Alison Knopf
Publié: (2024)

Ob‐gyns respond to recent FDA discussion on SSRIs in pregnancy
par: Alison Knopf
Publié: (2025)

FDA warns against ultra‐processed food risks to children
Publié: (2025)

FDA warns against accidental overdose on fentanyl patches by children
par: Alison Knopf
Publié: (2024)

FDA approves drug to treat neurologic manifestations of Hunter syndrome
Publié: (2026)

Prescription stimulant prescribing, nonmedical use, and shortages: US FDA research and response
Publié: (2025)

FDA requests removal of suicide warnings from two GLP‐1 labels
Publié: (2026)

2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
par: Alison Knopf
Publié: (2026)

FDA approves first genetic test to help identify risk of developing opioid use disorder
Publié: (2024)

Viloxazine moderate dose associated with good ADHD outcomes
par: Alison Knopf
Publié: (2024)

Importance of good sleep in helping prevent subsequent suicidal behaviors
par: Alison Knopf
Publié: (2024)

Neuroscientist urges a focus on the joy of adolescent experimentation
par: Alison Knopf
Publié: (2025)

Why a complete medical exam is necessary prior to diagnosing ADHD
par: Alison Knopf
Publié: (2024)

Age of autism diagnosis determined by traits as well as genes
par: Alison Knopf
Publié: (2025)

Pediatric obesity treatment yields long‐lasting health effects
par: Alison Knopf
Publié: (2025)

HHS criticizes many psychiatric medications for youth
par: Alison Knopf
Publié: (2025)

Buprenorphine only works if people take it
par: Alison Knopf
Publié: (2025)

Puberty, trauma, and internalizing symptoms in young girls
par: Alison Knopf
Publié: (2025)

Patient Information Sheet
Publié: (2025)

Patient Information Sheet
par: Alison Knopf
Publié: (2025)

APA finds many daily online gamblers started as 18–25 year olds
par: Alison Knopf
Publié: (2025)

AACAP reaffirms commitment to gender‐affirming care, opposes removing specialized crisis line
par: Alison Knopf
Publié: (2025)

How non‐core autism symptoms in children affect caregivers
par: Alison Knopf
Publié: (2025)

Automatic protocols for perinatal drug testing harm the maternal–child relationship
par: Alison Knopf
Publié: (2025)

Hypothetical study finds buprenorphine more cost‐effective than methadone for pregnant women with OUD
par: Alison Knopf
Publié: (2025)

Off‐label LAI antipsychotics effective for treating bipolar disorder in teens
par: Alison Knopf
Publié: (2025)

HHS Secretary says ‘Autism Epidemic Runs Rampant’
par: Alison Knopf
Publié: (2025)

AAP urges caution in diagnosing, treating PANS
par: Alison Knopf
Publié: (2025)

Inflammatory proteins during pregnancy increases risk of disorders in children
par: Alison Knopf
Publié: (2025)

Treatments needed for young people with stimulant use disorders
par: Alison Knopf
Publié: (2025)

Cannabis prevention is suicide prevention
par: Alison Knopf
Publié: (2025)

Medical groups issue joint statement on psychotropic safety
par: Alison Knopf
Publié: (2025)

Link between cannabis use and schizophrenia is likely causal, especially for teens
par: Alison Knopf
Publié: (2025)

Age‐specific providers needed for transition‐age youth
par: Alison Knopf
Publié: (2025)

Patient Information Sheet
par: Alison Knopf
Publié: (2025)

TMS‐connectivity response as predictor of TMS success
par: Alison Knopf
Publié: (2025)

Transdiagnostic online treatment helpful for emotion dysregulation
par: Alison Knopf
Publié: (2025)